Noubar Afeyan - Jun 7, 2023 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
Director, 10%+ Owner
Signature
/s/ Barbara Chan as Attorney-in-Fact for Noubar B. Afeyan, Ph.D.
Stock symbol
OMGA
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 04:05 PM
Previous filing
Jun 2, 2023
Next filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +18.1K $0.00 18.1K Jun 7, 2023 Common Stock 18.1K $8.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.